UK’s Revamped Clinical Trials Framework To Offer Faster Application Review Timelines Than EU
Changes Represent Biggest Overhaul In UK Clinical Trials Regulation In Over 20 Years
Executive Summary
The UK has finalized plans for delivering what it believes will be a stable and streamlined clinical trials framework following its departure from the EU. Transparency, patient involvement and diversity are high on the agenda.
You may also be interested in...
UK To Launch Notification Scheme For Low-Risk Trials
The UK regulator’s new clinical trials notification scheme will allow researchers to proceed with low-risk studies without the need for further assessment.
UK Aims To Identify Gaps In Current Landscape For Patient Involvement In Trial Design
The UK is making progress with framing guidance on meaningful involvement of patients and public in clinical trials.
£10m Cash Boost For UK Regulator To Speed Up New Drug Approvals
An injection of new money should provide something of a shot in the arm for the UK’s drugs regulator as it deals with post-Brexit realities.